TipRanks
Go Ultimate55% OFF

Guard Therapeutics International AB (DPHA) Income Statement

Guard Therapeutics International AB Income Statement

Last quarter (Q1 2026), Guard Therapeutics International AB's total revenue was $0.00. In Q1, Guard Therapeutics International AB's net income was $-6.35M. See Guard Therapeutics International AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
$ 0.00$ 0.00$ -15.00K$ -15.00K$ -15.00K
$ 107.74M$ 99.91M$ 115.07M$ 113.63M$ 81.28M
Depreciation and Amortization$ 0.00$ 15.00K$ 15.00K$ 15.00K$ 15.00K
$ -107.74M$ -100.23M$ -114.91M$ -112.82M$ -82.01M
$ -107.74M$ -99.91M$ -115.07M$ -114.92M$ -81.90M
$ -1.11M$ 3.84M$ 1.75M$ 2.08M$ -130.00K
$ -108.85M$ -96.07M$ -113.32M$ -112.84M$ -82.03M
$ -108.85M$ -96.07M$ -113.32M$ -110.76M$ -82.16M
Per Share Metrics
Basic EPS$ -6.04$ -8.62$ -11.26$ -15.72$ -0.74
Diluted EPS$ -6.04$ -8.62$ -11.26$ -15.72$ -0.74
Weighted Average Shares Outstanding18.03M11.15M10.06M7.05M110.30M
Weighted Average Shares Outstanding (Diluted)18.03M11.15M10.06M7.05M110.30M

Currency in SEK

Guard Therapeutics International AB Earnings and Revenue History

-120M-80M-40M00 %0.4 %0.8 %1.2 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin